NOTE: This study is no longer accepting participants.
The MIND Group at the University of Minnesota is conducting a survey to learn about how genetic and neurodevelopmental differences impact children’s behavioral strengths and challenges. The information you provide will help us to understand the best ways to support children and adolescents like your child.
About the Survey
Who can participate?
Parents of 3–17-year-olds living in the U.S., Canada, New Zealand, and Australia are eligible to participate.
What will happen in the study?
If the individual qualifies and decides to be in this research study, they will complete a brief survey online. The survey should take about 10–20 minutes to complete. The survey may be completed in more than one sitting.
What are the good things that can happen from this research?
We cannot promise any benefits to you or others from your taking part in this research. However, your participation will help us learn whether there are better ways to monitor and support social development in children with different genetic and neurodevelopmental differences.
What are the bad things that can happen from this research?
The main risk of this study is that you may find some of the questions on the questionnaires difficult or boring to answer, or you may feel that they are sensitive or personal. You are free to not answer any question if you find it upsetting. Another risk of this study is that your information could become known to someone not involved in the study.
Will you/your child be paid to complete this survey?
If you take part in this research study, you can elect to be entered into a drawing for one of four prepaid Visa gift cards of the following value:
- One $100 gift card
- One $50 gift card
- Two $25 gift cards
To be entered, you must provide your email address. This information will be entered separately after you finish the survey and will not be connected to your survey responses in any way.
Our Most Recent Opportunities
IMPACT-FXS: Investigating Multiple Pathways And Combined Treatments for FXS
Healx is conducting a Phase 2, placebo-controlled study in adolescent and adult males with fragile X syndrome (FXS). The purpose of this study is to confirm whether Healx's drug candidates are safe and work as intended to reduce symptoms of FXS.
Survey: Developing a Gold Standard for Tracking Adult Functional Outcomes in Developmental Disabilities (AFS Study)
University of Pittsburgh is conducting this research to develop the Adult Functioning Scale (AFS), a new survey being designed to capture outcomes in the areas of social functioning, employment, independence, and satisfaction for individuals with various developmental disorders.
Study: Aging in Toolbox
Researchers around the country are conducting a study to better understand cognitive profiles in adults with intellectual disability. This study is an extension of the ongoing Toolbox Study, which is aimed to optimize cognitive assessment tools for children and young adults with intellectual disabilities.
Validation of Fragile X-Associated Tremor Ataxia Syndrome Rating Scale (FXTAS-RS)
Rush University is conducting a research study to validate a rating scale created to assess the motor symptoms of people with FXTAS – the “Fragile X-Associated Tremor Ataxia Syndrome Rating Scale (FXTAS-RS)”
Study: Connection between Cognition and Genetic Factors in Adults with FXS
Drs. Craig Erickson and Lauren Schmitt at Cincinnati Children’s Hospital are conducting a series of research studies to learn about the brain and cognition and how they are connected with genetic factors related to FXS.
Study: UNC Brain Development Research Study of Infants with Fragile X Syndrome
UNC Chapel Hill is conducting a research study to learn about the early brain and behavioral development of infants with FXS to aid in the future development of better supports and treatments.